| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.981 | 0.003 | 0.988 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.963 0.003 DBMET03435 0.988 0.002 DBMET03436 0.965 0.003 DBMET03437 0.948 0.003 DBMET03438 | DBMET03436 | |
| 0.934 | 0.004 | 0.946 | Tyrosine kinase inhibitor | 0.906 0.004 DBMET03435 0.946 0.004 DBMET03436 0.921 0.004 DBMET03437 0.919 0.004 DBMET03438 | DBMET03436 | |
| 0.839 | 0.003 | 0.883 | Janus tyrosine kinase 3 inhibitor | 0.778 0.003 DBMET03435 0.883 0.003 DBMET03436 0.755 0.003 DBMET03437 0.795 0.003 DBMET03438 | DBMET03436 | |
| 0.786 | 0.002 | 0.804 | Janus tyrosine kinase 2 inhibitor | 0.769 0.003 DBMET03435 0.804 0.002 DBMET03436 0.77 0.003 DBMET03437 0.771 0.003 DBMET03438 | DBMET03436 | |
| 0.698 | 0.004 | 0.862 | Cyclin-dependent kinase 2 inhibitor | 0.586 0.005 DBMET03435 0.862 0.004 DBMET03436 0.546 0.005 DBMET03437 0.511 0.005 DBMET03438 | DBMET03436 | |
| 0.682 | 0.001 | 0.711 | Tyk2 inhibitor | 0.667 0.002 DBMET03435 0.711 0.001 DBMET03436 0.67 0.001 DBMET03437 0.667 0.002 DBMET03438 | DBMET03436 | |
| 0.493 | 0.006 | 0.64 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.421 0.009 DBMET03435 0.64 0.004 DBMET03436 0.382 0.013 DBMET03437 0.425 0.009 DBMET03438 | DBMET03436 | |
| 0.484 | 0.002 | 0.545 | Janus tyrosine kinase 1 inhibitor | 0.436 0.002 DBMET03435 0.545 0.002 DBMET03436 0.432 0.002 DBMET03437 0.445 0.002 DBMET03438 | DBMET03436 | |
| 0.482 | 0.004 | 0.703 | CDK2/cyclin A inhibitor | 0.39 0.005 DBMET03435 0.703 0.004 DBMET03436 0.363 0.005 DBMET03437 0.349 0.005 DBMET03438 | DBMET03436 | |
| 0.44 | 0.009 | 0.619 | Cyclin-dependent kinase inhibitor | 0.327 0.017 DBMET03435 0.619 0.005 DBMET03436 0.268 0.024 DBMET03437 0.314 0.018 DBMET03438 | DBMET03436 | |
| 0.418 | 0.003 | 0.485 | Polo-like kinase-4 inhibitor | 0.411 0.003 DBMET03435 0.485 0.002 DBMET03436 0.391 0.003 DBMET03437 0.436 0.003 DBMET03438 | DBMET03436 | |
| 0.403 | 0.005 | 0.544 | CDK/cyclin complex inhibitor | 0.313 0.009 DBMET03435 0.544 0.004 DBMET03436 0.264 0.012 DBMET03437 0.332 0.008 DBMET03438 | DBMET03436 | |
| 0.401 | 0.004 | 0.429 | Cyclin A2 inhibitor | 0.3 0.005 DBMET03435 0.429 0.004 DBMET03436 0.164 0.012 DBMET03437 0.271 0.006 DBMET03438 | DBMET03436 | |
| 0.395 | 0.004 | 0.434 | Cyclin A inhibitor | 0.283 0.006 DBMET03435 0.434 0.004 DBMET03436 0.141 0.014 DBMET03437 0.239 0.007 DBMET03438 | DBMET03436 | |
| 0.406 | 0.026 | 0.461 | Potassium channel (Voltage-sensitive) blocker | 0.31 0.046 DBMET03435 0.174 0.117 DBMET03436 0.461 0.018 DBMET03437 0.215 0.086 DBMET03438 | DBMET03437 | |
| 0.394 | 0.023 | 0.412 | Potassium channel blocker | 0.355 0.031 DBMET03435 0.172 0.113 DBMET03436 0.412 0.021 DBMET03437 0.247 0.068 DBMET03438 | DBMET03437 | |
| 0.387 | 0.042 | 0.431 | Nootropic | 0.431 0.031 DBMET03435 0.383 0.043 DBMET03436 0.411 0.036 DBMET03437 0.333 0.059 DBMET03438 | DBMET03435 | |
| 0.307 | 0.005 | 0.332 | ALK inhibitor | 0.268 0.007 DBMET03435 0.332 0.005 DBMET03436 0.208 0.01 DBMET03437 0.304 0.005 DBMET03438 | DBMET03436 | |
| 0.305 | 0.005 | 0.325 | Beta amyloid protein antagonist | 0.272 0.007 DBMET03435 0.325 0.005 DBMET03436 0.164 0.032 DBMET03437 0.239 0.009 DBMET03438 | DBMET03436 | |
| 0.292 | 0.054 | 0.406 | Antiamyloidogenic | 0.202 0.098 DBMET03435 0.406 0.027 DBMET03436 0.221 0.086 DBMET03437 0.163 0.13 DBMET03438 | DBMET03436 | |
| 0.365 | 0.135 | 0.377 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.377 0.122 DBMET03435 0.365 0.135 DBMET03438 | DBMET03435 | |
| 0.243 | 0.019 | 0.264 | 5 Hydroxytryptamine 3E antagonist | 0.184 0.096 DBMET03435 0.164 0.156 DBMET03437 0.264 0.011 DBMET03438 | DBMET03438 | |
| 0.228 | 0.023 | 0.335 | Glycogen synthase kinase-3 beta inhibitor | 0.196 0.03 DBMET03435 0.335 0.011 DBMET03436 0.127 0.056 DBMET03437 0.262 0.018 DBMET03438 | DBMET03436 | |
| 0.23 | 0.025 | 0.327 | Glycogen synthase kinase-3 inhibitor | 0.199 0.032 DBMET03435 0.327 0.013 DBMET03436 0.141 0.049 DBMET03437 0.27 0.019 DBMET03438 | DBMET03436 | |
| 0.312 | 0.124 | 0.312 | MAP kinase kinase 6 inhibitor | 0.255 0.184 DBMET03435 0.269 0.168 DBMET03436 0.312 0.124 DBMET03438 | ||
| 0.22 | 0.035 | 0.272 | Polo-like kinase-3 inhibitor | 0.202 0.044 DBMET03435 0.272 0.018 DBMET03436 0.236 0.029 DBMET03437 0.254 0.023 DBMET03438 | DBMET03436 | |
| 0.186 | 0.035 | 0.186 | Aurora-B kinase inhibitor | 0.118 0.066 DBMET03435 0.173 0.039 DBMET03436 0.162 0.042 DBMET03438 | ||
| 0.263 | 0.113 | 0.328 | Angiogenesis inhibitor | 0.227 0.141 DBMET03435 0.328 0.08 DBMET03436 0.229 0.14 DBMET03437 0.24 0.13 DBMET03438 | DBMET03436 | |
| 0.222 | 0.078 | 0.307 | HERG channel blocker | 0.154 0.127 DBMET03435 0.307 0.047 DBMET03437 0.253 0.065 DBMET03438 | DBMET03437 | |
| 0.14 | 0.005 | 0.157 | Polo-like kinase-2 inhibitor | 0.131 0.006 DBMET03435 0.157 0.004 DBMET03436 0.124 0.009 DBMET03437 0.147 0.005 DBMET03438 | DBMET03436 | |
| 0.262 | 0.137 | 0.265 | Toll-Like receptor 7 agonist | 0.232 0.165 DBMET03435 0.265 0.135 DBMET03436 0.232 0.165 DBMET03438 | DBMET03436 | |
| 0.258 | 0.141 | 0.262 | Toll-Like receptor agonist | 0.229 0.17 DBMET03435 0.262 0.137 DBMET03436 0.229 0.169 DBMET03438 | DBMET03436 | |
| 0.164 | 0.05 | 0.164 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.155 0.064 DBMET03435 0.16 0.056 DBMET03436 0.13 0.117 DBMET03437 0.164 0.05 DBMET03438 | ||
| 0.184 | 0.083 | 0.209 | Focal adhesion kinase 2 inhibitor | 0.176 0.092 DBMET03435 0.209 0.063 DBMET03436 0.193 0.075 DBMET03438 | DBMET03436 | |
| 0.231 | 0.131 | 0.608 | Immunomodulator | 0.237 0.126 DBMET03435 0.285 0.091 DBMET03436 0.608 0.011 DBMET03437 | DBMET03437 | |
| 0.119 | 0.023 | 0.119 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.085 0.037 DBMET03435 0.08 0.041 DBMET03436 0.073 0.048 DBMET03437 0.087 0.036 DBMET03438 | ||
| 0.13 | 0.041 | 0.235 | Cyclin-dependent kinase 9 inhibitor | 0.086 0.081 DBMET03435 0.235 0.016 DBMET03436 0.114 0.05 DBMET03438 | DBMET03436 | |
| 0.244 | 0.155 | 0.3 | Calcium channel activator | 0.276 0.117 DBMET03435 0.3 0.092 DBMET03438 | DBMET03438 | |
| 0.29 | 0.205 | 0.382 | Caspase 9 stimulant | 0.382 0.122 DBMET03436 0.334 0.159 DBMET03438 | DBMET03436 | |
| 0.144 | 0.059 | 0.176 | Aurora-C kinase inhibitor | 0.134 0.075 DBMET03435 0.176 0.029 DBMET03436 0.126 0.092 DBMET03437 0.154 0.045 DBMET03438 | DBMET03436 | |
| 0.125 | 0.05 | 0.125 | Granulocyte macrophage colony stimulating factor antagonist | 0.098 0.074 DBMET03438 | ||
| 0.076 | 0.009 | 0.076 | Alpha 1L adrenoreceptor antagonist | 0.067 0.014 DBMET03435 0.051 0.039 DBMET03436 0.056 0.029 DBMET03437 0.076 0.009 DBMET03438 | ||
| 0.221 | 0.175 | 0.278 | Immunosuppressant | 0.278 0.129 DBMET03436 | DBMET03436 | |
| 0.148 | 0.102 | 0.152 | Cyclin-dependent kinase 3 inhibitor | 0.139 0.124 DBMET03435 0.152 0.091 DBMET03436 0.148 0.102 DBMET03438 | DBMET03436 | |
| 0.203 | 0.158 | 0.203 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.199 0.168 DBMET03436 0.203 0.158 DBMET03438 | ||
| 0.065 | 0.021 | 0.065 | 5 Hydroxytryptamine 1B agonist | 0.057 0.03 DBMET03435 | ||
| 0.093 | 0.052 | 0.13 | Antineoplastic alkaloid | 0.098 0.049 DBMET03435 0.13 0.034 DBMET03436 0.093 0.052 DBMET03438 | DBMET03436 | |
| 0.097 | 0.056 | 0.097 | Toll-Like receptor 3 antagonist | 0.097 0.056 DBMET03438 | ||
| 0.121 | 0.081 | 0.685 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.685 0.004 DBMET03437 0.134 0.071 DBMET03438 | DBMET03437 | |
| 0.071 | 0.031 | 0.077 | CDK4/cyclin D1 inhibitor | 0.056 0.043 DBMET03435 0.077 0.026 DBMET03436 0.077 0.026 DBMET03438 | DBMET03438 | |
| 0.103 | 0.064 | 0.136 | Aurora-A kinase inhibitor | 0.136 0.046 DBMET03436 0.093 0.072 DBMET03438 | DBMET03436 | |
| 0.074 | 0.037 | 0.096 | CDK1/cyclin B inhibitor | 0.057 0.05 DBMET03435 0.096 0.026 DBMET03436 0.085 0.031 DBMET03438 | DBMET03436 | |
| 0.088 | 0.051 | 0.104 | AXL receptor tyrosine kinase inhibitor | 0.104 0.036 DBMET03438 | DBMET03438 | |
| 0.118 | 0.088 | 0.143 | Toll-Like receptor 9 antagonist | 0.143 0.068 DBMET03438 | DBMET03438 | |
| 0.046 | 0.028 | 0.054 | Phosphodiesterase 3B inhibitor | 0.053 0.023 DBMET03435 0.054 0.022 DBMET03436 0.053 0.023 DBMET03438 | DBMET03436 | |
| 0.022 | 0.006 | 0.024 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.01 DBMET03435 0.024 0.004 DBMET03436 0.02 0.008 DBMET03437 0.022 0.006 DBMET03438 | DBMET03436 | |
| 0.116 | 0.101 | 0.126 | Activin receptor-like kinase 2 inhibitor | 0.126 0.089 DBMET03438 | DBMET03438 | |
| 0.028 | 0.016 | 0.037 | Histone deacetylase 6 inhibitor | 0.028 0.016 DBMET03435 0.037 0.013 DBMET03436 0.023 0.02 DBMET03438 | DBMET03436 | |
| 0.029 | 0.016 | 0.037 | Histone deacetylase class IIb inhibitor | 0.029 0.016 DBMET03435 0.037 0.013 DBMET03436 0.023 0.02 DBMET03438 | DBMET03436 | |
| 0.072 | 0.06 | 0.072 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.03 | 0.019 | 0.037 | Histone deacetylase class II inhibitor | 0.03 0.019 DBMET03435 0.037 0.014 DBMET03436 | DBMET03436 | |
| 0.063 | 0.053 | 0.094 | Check point kinase 1 inhibitor | 0.094 0.031 DBMET03436 | DBMET03436 | |
| 0.038 | 0.03 | 0.038 | Dopamine D3 agonist | 0.038 0.03 DBMET03438 | ||
| 0.074 | 0.068 | 0.076 | MAP kinase 7 inhibitor | 0.076 0.062 DBMET03438 | DBMET03438 | |
| 0.028 | 0.024 | 0.039 | Histone deacetylase 11 inhibitor | 0.034 0.02 DBMET03435 0.039 0.018 DBMET03436 | DBMET03436 | |
| 0.028 | 0.024 | 0.039 | Histone deacetylase class IV inhibitor | 0.034 0.02 DBMET03435 0.039 0.018 DBMET03436 | DBMET03436 | |
| 0.078 | 0.075 | 0.088 | mTOR complex 2 inhibitor | 0.088 0.05 DBMET03436 0.086 0.055 DBMET03438 | DBMET03436 | |
| 0.127 | 0.125 | 0.15 | MAP kinase kinase 4 inhibitor | 0.129 0.117 DBMET03435 0.15 0.062 DBMET03436 0.139 0.087 DBMET03438 | DBMET03436 | |
| 0.052 | 0.051 | 0.056 | CDK4/cyclin D inhibitor | 0.053 0.049 DBMET03436 0.056 0.044 DBMET03438 | DBMET03438 | |
| 0.028 | 0.028 | 0.03 | Potassium channel (Inward rectifier) 1 blocker | 0.03 0.022 DBMET03438 | DBMET03438 | |
| 0.067 | 0.067 | 0.075 | Focal adhesion kinase 1 inhibitor | 0.075 0.055 DBMET03438 | DBMET03438 | |
| 0.054 | 0.055 | 0.055 | Potassium channel (Ca-activated) blocker | 0.055 0.052 DBMET03438 | DBMET03438 | |
| 0.047 | 0.055 | 0.06 | CDK9/cyclin T1 inhibitor | 0.06 0.04 DBMET03436 0.057 0.043 DBMET03438 | DBMET03436 | |
| 0.05 | 0.063 | 0.071 | Phosphodiesterase III inhibitor | 0.071 0.043 DBMET03435 0.061 0.051 DBMET03437 0.064 0.048 DBMET03438 | DBMET03435 | |
| 0.062 | 0.074 | 0.09 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.09 0.042 DBMET03436 | DBMET03436 | |
| 0.092 | 0.105 | 0.108 | Activin receptor-like kinase 4 inhibitor | 0.108 0.07 DBMET03436 | DBMET03436 | |
| 0.08 | 0.1 | 0.093 | Interleukin 12 antagonist | 0.093 0.065 DBMET03435 | DBMET03435 | |
| 0.042 | 0.064 | 0.046 | Alpha 1b adrenoreceptor agonist | 0.046 0.045 DBMET03438 | DBMET03438 | |
| 0.082 | 0.108 | 0.098 | mTOR complex 1 inhibitor | 0.098 0.067 DBMET03438 | DBMET03438 | |
| 0.152 | 0.18 | 0.172 | MAP-kinase-activated kinase 5 inhibitor | 0.163 0.16 DBMET03436 0.172 0.145 DBMET03438 | DBMET03438 | |
| 0.029 | 0.059 | 0.035 | ATM kinase inhibitor | 0.035 0.029 DBMET03438 | DBMET03438 | |
| 0.048 | 0.081 | 0.071 | Alpha 1 adrenoreceptor antagonist | 0.071 0.058 DBMET03435 | DBMET03435 | |
| 0.033 | 0.069 | 0.049 | Mineralocorticoid receptor antagonist | 0.049 0.032 DBMET03436 | DBMET03436 | |
| 0.024 | 0.06 | 0.037 | Estrogen-related receptor beta antagonist | 0.037 0.014 DBMET03436 | DBMET03436 | |
| 0.036 | 0.076 | 0.057 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.057 0.035 DBMET03436 | DBMET03436 | |
| 0.039 | 0.08 | 0.06 | Alpha 1a adrenoreceptor antagonist | 0.06 0.058 DBMET03435 | DBMET03435 | |
| 0.051 | 0.094 | 0.073 | TIE-2 antagonist | 0.073 0.065 DBMET03438 | DBMET03438 | |
| 0.052 | 0.097 | 0.072 | TIE antagonist | 0.072 0.068 DBMET03438 | DBMET03438 | |
| 0.037 | 0.091 | 0.055 | Phosphatidylinositol kinase inhibitor | 0.055 0.047 DBMET03436 | DBMET03436 | |
| 0.081 | 0.139 | 0.101 | CDK3/cyclin E inhibitor | 0.101 0.086 DBMET03436 | DBMET03436 | |
| 0.206 | 0.265 | 0.33 | Apoptosis agonist | 0.33 0.152 DBMET03436 | DBMET03436 | |
| 0.108 | 0.182 | 0.217 | Antimitotic | 0.217 0.075 DBMET03436 | DBMET03436 | |
| 0.045 | 0.121 | 0.062 | Phosphodiesterase 1C inhibitor | 0.062 0.043 DBMET03438 | DBMET03438 | |
| 0.054 | 0.146 | 0.087 | 5 Hydroxytryptamine 2 antagonist | 0.087 0.083 DBMET03438 | DBMET03438 | |
| 0.089 | 0.183 | 0.118 | DNA repair enzyme inhibitor | 0.108 0.101 DBMET03436 0.118 0.077 DBMET03438 | DBMET03438 | |
| 0.061 | 0.155 | 0.096 | 5 Hydroxytryptamine 2B antagonist | 0.096 0.088 DBMET03438 | DBMET03438 | |
| 0.049 | 0.145 | 0.112 | Topoisomerase I inhibitor | 0.112 0.06 DBMET03436 | DBMET03436 | |
| 0.055 | 0.158 | 0.133 | DNA intercalator | 0.133 0.051 DBMET03437 | DBMET03437 | |
| 0.211 | 0.318 | 0.379 | Antiinflammatory | 0.379 0.152 DBMET03436 | DBMET03436 | |
| 0.034 | 0.142 | 0.055 | Phosphodiesterase 1B inhibitor | 0.055 0.049 DBMET03438 | DBMET03438 | |
| 0.038 | 0.171 | 0.068 | Secretase beta inhibitor | 0.068 0.053 DBMET03436 | DBMET03436 | |
| 0.043 | 0.182 | 0.105 | Cyclin-dependent kinase 5 inhibitor | 0.105 0.071 DBMET03436 | DBMET03436 | |
| 0.053 | 0.206 | 0.142 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.142 0.083 DBMET03436 | DBMET03436 | |
| 0.089 | 0.276 | 0.163 | Neurotrophic factor enhancer | 0.163 0.119 DBMET03436 | DBMET03436 | |
| 0.121 | 0.354 | 0.388 | GABA C receptor rho-3 antagonist | 0.388 0.067 DBMET03436 | DBMET03436 | |
| 0.033 | 0.267 | 0.092 | Ephrin antagonist | 0.092 0.07 DBMET03437 | DBMET03437 | |
| 0.065 | 0.316 | 0.164 | GABA C receptor rho-2 antagonist | 0.164 0.057 DBMET03436 | DBMET03436 | |
| 0.02 | 0.276 | 0.093 | Protein kinase (CK2) inhibitor | 0.093 0.07 DBMET03436 | DBMET03436 | |
| 0.03 | 0.291 | 0.072 | Phosphodiesterase VIII inhibitor | 0.072 0.049 DBMET03438 | DBMET03438 | |
| 0.141 | 0.422 | 0.436 | Calcium channel L-type activator | 0.436 0.058 DBMET03435 | DBMET03435 | |
| 0.019 | 0.303 | 0.09 | Protein kinase (CK2) alpha inhibitor | 0.09 0.087 DBMET03436 | DBMET03436 | |
| 0.02 | 0.351 | 0.188 | Protein-tyrosine kinase Lyn inhibitor | 0.188 0.05 DBMET03437 | DBMET03437 | |
| 0.027 | 0.564 | 0.144 | Peroxidase inhibitor | 0.144 0.081 DBMET03436 | DBMET03436 | |
| 0.019 | 0.707 | 0.309 | Tumour necrosis factor alpha release inhibitor | 0.309 0.05 DBMET03437 | DBMET03437 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |